Volume : 09, Issue : 12, December – 2022
Title:
65.FORMULATION AND EVALUATION OF SIMVASTATIN MATRIX TABLETS
Authors :
H. Padmalatha
Abstract :
Formulation and evaluation of the sustained release tablets of the Simvastatin. The before going to formulate the tablets the preformulation studies are carried out such as FTIR,calibration,organoleptic characters. The formulation is developed by using different types of the super disintegrates such as the hpmc and xanthin gum in different trails. The pre compression parameters such as angle of repose ,bulk density, true density, compressability index, these are found to be within the limits. The oral dispersible tablets of Nizatidine tablets are prepared by the direct compression method. The talc used as glidant and lactose used as lubricant mcc used as filler. The after development of oral dispersible tablets are undergo for evaluation parameters. Such as weight variation, thickness, friability, drug content, disintegration, and In vitro dissolution studies. They all are found in within range of limits. The in vitro drug release studies carried out by USP-II apparatus. The buffer medium 6.8 . The optimised formulation undergo for stability studies for 3 months .In stability studies the drug content and drug release studies carried out. These no degradation takes place in the drug content and drug release studies.
Key words: Formulation, Evaluation of Simvastatin, matrix tablets
Cite This Article:
Please cite this article in press H. Padmalatha , Formulation And Evaluation Of Simvastatin Matrix Tablets., Indo Am. J. P. Sci, 2022; 09(12).
Number of Downloads : 10
References:
2. Singh R. R. Design, Formulation and In Vitro Evaluation of Lamivudine HCl Sustained-Release Tablets. International Journal of Research in Pharmaceutical and Nano Sciences, 3(2): 113 – 121, 2014.
3. Ansel HC and Loyyd VA. Pharmaceutical dosage forms and Drug Delivery System. Lippincott’s Williams and Wilking, Hong Kon, 8:275-280, 1999.
4. Khullar P, Khar RK, and Agarwal SP., Guar Gum as a hydrophilic matrix for preparation of Theophylline Controlled Release dosage form, Ind. J. Pharm. Sc., 61(6): 342-345, 1999.
5. Verhoeven J et al., Controlled-release formulations, a hydrophilic matrix containing furosemide, Int. J. Pharm, 45: 65, 1988.
6. Kumar R. G., Kumar J. N. S., Babu A., and Anjaneyulu M. V., Formulation Development and Evaluation of Lamotrigine Sustained-Release Tablets Using 32 Factorial Design, International Journal of Pharmaceutical Sciences and Research, 6(4): 1746-1752. 2015.
7. Sujja A. J., Munday D. L., and Khan K. A., Development and evaluation of a multiple-unit oral sustained release dosage form for S (+)- Ibuprofen: preparation and release kinetics. Int. J. Pharm, 193(1):73-84, 1999.
8. Martindale: The Complete Drug Reference, 34th ed. Simvastatin, Pharmaceutical Press, London. 997-1000, 2005.
9. WHO Model List of Essential Medicines (19th List)” World Health Organization. April 2015 from the original on 13 December 2016.
10. Pande A. V., Vaidya P. D., Arora A., Dhoka M. V., Int J Pharm Biomedicine Research; : 122-128. .2010
11. Jimenez-Caste lanos M. R., Zia H, Rhodes C. T., Drug Dev Ind Pharm. 19, (143), 1993.
12 Aulton M. E., Pharmaceutics the science of dosage form design. 2nd ed. New York: Churchil Livingstone, pp.397-421, 2002.
13 Mathiow E, Donald E. C., Claus-Michael L., Bioadhesive drug Delivery System: Fundamental s, Novel Approaches and developments, Marcel Dekker. 1999.